FIELD: medicine, biology. SUBSTANCE: invention relates to preparations stimulating DNA synthesis. Invention proposes the use of β-form of methyluracil as stimulating agent of endogenic DNA synthesis. This use can be used at all cases of DNA damage (effect of radiation, intoxication with cytostatics and others). EFFECT: enhanced effectiveness of stimulation. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ACTIVATING ALVEOLAR MACROPHAGES | 1993 |
|
RU2063226C1 |
| NOVEL CRYSTALLINE MODIFICATION OF 5-FLUORO-1-(TETRAHYDRO-2-FURYL)-URACIL AND COMPLEX COMPOUNDS BASED ON THEREOF EXHIBITING ANTITUMOR EFFECT | 1998 |
|
RU2198171C2 |
| METHYLURACIL LINIMENT | 1992 |
|
RU2007997C1 |
| SUBSTANCE SHOWING RADIOPROTECTIVE EFFECT | 1993 |
|
RU2104007C1 |
| AGENT STIMULATING REPARATION OF DAMAGES AND ELICITING TISSUE-, ORGAN- AND STAGE-SPECIFICITY AND ANTIVIRAL ACTIVITY | 2003 |
|
RU2238756C1 |
| MEDICATION FOR TREATING AND PREVENTION OF ALCOHOLISM | 2014 |
|
RU2574001C1 |
| METHOD OF DETERMINING BIOLOGICAL INEQUIVALENCE OF NANODIAMONDS | 2013 |
|
RU2538611C1 |
| MEANS FOR TREATMENT AND PREVENTION OF SLEEP DISORDERS | 2014 |
|
RU2566713C1 |
| METHOD OF TUBERCULOSIS TREATMENT | 1994 |
|
RU2099056C1 |
| SUSPENDED METHYLURACIL FORMULATION | 1992 |
|
RU2007998C1 |
